hre 664 has been researched along with Bacterial Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauernfeind, A; Jungwirth, R; Schweighart, S | 1 |
| Isert, D; Johnson, C; Klesel, N; Limbert, M; Schrinner, E; Seibert, G | 1 |
2 other study(ies) available for hre 664 and Bacterial Disease
| Article | Year |
|---|---|
In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Ceftazidime; Culture Media; Enterobacteriaceae; Germany, West; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1989 |
HRE 664, a new parenteral penem. II. Evaluation of the pharmacokinetic behavior and the chemotherapeutic activity in animals.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Infections; Biological Assay; Cefotaxime; Dogs; Lactams; Macaca; Mice; Rats | 1987 |